- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UK-05-0005388

About Suncare Pharmaceuticals Private Limited
Data last updated:
Suncare Pharmaceuticals Private Limited is a private limited company based in Dehradun, Uttarakhand, India. It operates in the alternative and holistic medicine segment of the healthcare sector. It was incorporated on 18 June 2002 and has been in existence for over 24 years.
The company is registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U31104UT2002PTC017112. Its GSTIN is 05AAHCS2332M1ZB (Uttarakhand). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹9.5 Lakh. It is led by directors Sanjay Kumar Sikaria and Sandeep Kumar Sikaria.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Dehradun, Uttarakhand.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.95 Cr, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹23.98 Lakh (net margin 8.1%) and EBITDA of ₹47.19 Lakh (EBITDA margin 16%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 1% over five years.
The company has about 5 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹9.2 Cr and satisfied charges of ₹2.24 Cr on record. Court records list 3 cases involving the company, including 3 filed by the company; 3 cases are pending.
Suncare Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-05-0005388). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website suncareformulations.com.
Company details
CIN history
Suncare Pharmaceuticals has one previous CIN (Corporate Identification Number): U31104WB2002PTC094759. The current CIN is U31104UT2002PTC017112, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U31104UT2002PTC017112 | Current |
| U31104WB2002PTC094759 | Previous |
Recognitions & Rankings of Suncare Pharmaceuticals
Contact details
Suncare Pharmaceuticals Private Limited's registered office is in Dehradun, Uttarakhand. Its website is suncareformulations.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No. 06 Pharmacity, Selaqui, Dehradun, Uttarakhand, India – 248011
- IndustryHealthcare, Alternative & Holistic Medicine
To see the full contact details of Suncare Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activities of Suncare Pharmaceuticals are manufacturing and support service to organizations. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and other support services to organizations. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| N | Support service to Organizations | N7 | Other support services to organizations |
To see the full business activity and turnover split of Suncare Pharmaceuticals Private Limited, buy the company report.
Financials of Suncare Pharmaceuticals Private Limited
FY 2025 filings availableSuncare Pharmaceuticals Private Limited reported revenue of ₹2.95 Cr (up 2% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 1% over five years, including 2% growth in the latest year. EBITDA rose 70% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹47.19 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹23.98 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 16% | ||||
| Net Profit Margin | 8.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Suncare Pharmaceuticals Private Limited, buy the company report.
Board of directors of Suncare Pharmaceuticals Private Limited
Suncare Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjay Kumar Sikaria Also directs: Suncare Laboratories LLP, Purbasha Resources Ltd, Suncare Formulations Private Limited and 3 more | Director | 18 Jun 2002 | 24 Years 4 Months | Current |
| Sandeep Kumar Sikaria | Director | 18 Jun 2006 | 20 Years 4 Months | Current |
Peer comparison
Suncare Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (Alternative Medicine, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Saltvae Pharmaceuticals Private Limited | ₹2.97 Cr (FY 2024) | 0.0% | Noida, Uttar Pradesh, India | |||
| Suncare Pharmaceuticals Private Limitedthis company | ₹2.95 Cr (FY 2024) | ₹23.98 Lakh | 8.1% | 2.0% | 5 | Dehradun, Uttarakhand, India |
| GMH Pharmaceuticals Pvt Ltd | ₹2.94 Cr (FY 2025) | -7.0% | Chandigarh, India | |||
| CMHP Private Limited | ₹2.93 Cr (FY 2025) | 20.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Suncare Pharmaceuticals Private Limited, buy the company report.
Auditor
Suncare Pharmaceuticals Private Limited is audited by KHATTAK KOCHHAR & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KHATTAK KOCHHAR & CO. | FY 2023 | 017124C |
Shareholding
The shareholding of Suncare Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Suncare Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 Sep 2020 | 100400501 | Axis Bank Limited | ₹8.5 Cr | Open | |
| 19 Aug 2020 | 100378785 | Axis Bank Limited | ₹70 Lakh | Open | |
| 09 Oct 2009 | 10185731 | Bank of Baroda | ₹2.24 Cr | Satisfied |
To see the full charge records of Suncare Pharmaceuticals Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
Suncare Pharmaceuticals Private Limited has 3 court cases on record: 3 filed by Suncare Pharmaceuticals. All cases are pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 0 | 3 |
Cases on record (2 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South East, Delhi | Commercial suit | Filed by the company against Maxkem Healthcare Pvt Ltd and 1 other | Pending |
| District court, Motihari, Bihar | Civil suit | Filed by the company against an individual | Pending |
To see the full case history of Suncare Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Suncare Pharmaceuticals Private Limited has 10 MSME Form 1 returns on record between 2019 and 2022, listing 136 overdue payments to 20 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 20)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Devson Impex Private Limited | |||
| an individual supplier | |||
| an individual supplier | |||
| S. S. Industries | |||
| Satnam Psyllium Industries |
To see the full MSME payment records of Suncare Pharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Suncare Pharmaceuticals Private Limited has a workforce of 5 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
GST
Suncare Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAHCS2332M1ZB | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Suncare Pharmaceuticals Private Limited, buy the company report.
Recent activity
Suncare Pharmaceuticals Private Limited has 3 board changes on record since 2002: 2 appointments and 1 cessation. The latest: Sushil Kumar Sikaria ceased to be Additional Director on 28 Dec 2020.
Frequently asked questions
Suncare Pharmaceuticals is an active private limited company based in Dehradun, Uttarakhand, India. The company works in alternative and holistic medicine, within the healthcare industry. It was incorporated on 18 June 2002 (24+ years old) and is registered under CIN U31104UT2002PTC017112.
Suncare Pharmaceuticals has 2 current directors:
- Sanjay Kumar Sikaria - Director
- Sandeep Kumar Sikaria - Director
The latest financial statements of Suncare Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Suncare Pharmaceuticals is 05AAHCS2332M1ZB, registered in Uttarakhand. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Suncare Pharmaceuticals is U31104UT2002PTC017112. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Suncare Pharmaceuticals has 3 court cases on record: 3 filed by the company. 3 are pending.
Suncare Pharmaceuticals was incorporated on 18 June 2002, making it 24+ years old. It is registered with the Registrar of Companies, Uttarakhand.
The peers of Suncare Pharmaceuticals by revenue are Saltvae Pharmaceuticals Private Limited, GMH Pharmaceuticals Pvt Ltd, CMHP Private Limited, all in the Healthcare industry (Alternative Medicine, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sushil Kumar Sikaria ceased to be Additional Director on 28 Dec 2020. Sandeep Kumar Sikaria was appointed as Director on 18 Jun 2006. Sanjay Kumar Sikaria was appointed as Director on 18 Jun 2002.
Yes, Suncare Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UK-05-0005388).
Suncare Pharmaceuticals has 10 MSME Form 1 returns on record between 2019 and 2022, listing 136 overdue payments to 20 micro and small suppliers. The latest return was filed on 20 Sep 2023.
Suncare Pharmaceuticals can be reached through the website suncareformulations.com. Its registered office is in Dehradun, Uttarakhand, India.